| http://www.w3.org/ns/prov#value | - Nestl?? expects the acquisition to provide it with a strong foothold in emerging markets, and also anticipates accretive earnings and margins in the first full year of the deal.The transaction, which is subject to regulatory approval and other closing conditions, would be completed by the first half of 2013.Pfizer's Chairman and Chief Executive Officer Ian Read, who is restructuring the company to
|
